Soph investors will recieve 2/3 of their allocation next week and 1/3 after the AGM if the cap raising is approved- Which Im sure it will be.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%